Earnings call transcript: Yes Bank posts Q2 2026 profit jump, shares slip

Yes Bank’s Q2 FY2027 net profit rose 65% year over year to INR 1,080 crore, while revenue of INR 47.04 billion slightly exceeded forecasts and EPS matched estimates. Net interest margin fell 12–14 bps sequentially to 2.6%; management expects it to remain around that level in Q3 before improving in Q4 and reiterated a 1.0% full-year FY2027 ROA outlook. The Supreme Court’s decision to set aside the INR 8,415 crore AT1 write-down could reduce pro forma CET1 by about 240 bps to 11.4%; management said it faces no immediate need to raise capital but is assessing its options. Shares were down 0.69% at $17.38.

Analysis

The key equity risk is not a near-term cash call but a weaker quality of capital: restoring AT1 liabilities reduces reported CET1 headroom, while coupon treatment and any capital response remain unresolved. That creates a second-order trade-off: management can protect growth by raising capital, but shareholders may bear dilution; avoiding a raise preserves ownership but could constrain risk-weighted asset growth or reduce the buffer against credit deterioration. The stated margin recovery is conditional, not yet earned. FCNR deployment and RIDF runoff may help, but deposit competition and loan repricing can absorb the benefit. Also separate recurring earnings from accounting support: the quarter included a material security-receipt gain, so headline profit growth is not a clean run-rate signal.

Near term, legal/accounting disclosures and coupon decisions are the dominant catalysts; over 1–3 months, watch actual NIM, FCNR deployment and capital plans. Over 6–18 months, the test is whether core returns improve enough to fund growth without dilutive capital. Management guidance is not independently verified. The contrarian upside is that a non-cash principal reinstatement may be treated as a solvable capital-structure issue rather than a solvency event, while an oversold share price can rebound on clarity. But that is not sufficient to underwrite the stock until the capital and recurring-earnings path is clearer.

Key Decisions for Investors

• Avoid chasing the oversold move; favor a relative underweight in Yes Bank versus a diversified, better-capitalized Indian private-bank basket rather than an outright short, which risks a sharp relief rally on legal or capital clarity.
• Reassess after the bank discloses the accounting implementation, coupon treatment and any capital action. The thesis improves if CET1 stabilizes without material dilution and reported NIM turns up alongside FCNR deployment; it weakens if capital raising is accelerated on shareholder-dilutive terms.
• Track Q3–Q4 core NIM, deposit costs, FCNR deployment, slippages and profit excluding security-receipt gains. A margin recovery that fails to appear, or credit deterioration that consumes capital, would falsify the recovery case.
• Do not value the stated payment-systems monetization as near-term earnings: revenue depends on future MDR rules and commercial sharing arrangements, neither of which is quantified in the available information.